Today's post is by Chris Letheby (Western Australia/Adelaide) on his new book Philosophy of Psychedelics (OUP 2021). We are in the midst of a psychedelic renaissance. “Classic” psychedelic drugs such as LSD and psilocybin are the objects of renewed scientific interest. Despite the chequered reputation of these substances, recent clinical trials have shown that psychedelics can be administered safely in controlled conditions, and may have a role in the treatment of various psychological maladies. There is even talk of a “new paradigm” in psychiatric treatment. But psychedelic-assisted psychotherapy (“psychedelic therapy”) has several unusual features that distinguish it from standard psychiatric treatments and raise intriguing questions. In my book Philosophy of Psychedelics (OUP 2021) I tackle some of these questions. The most striking feature of psychedelic therapy is that it involves the induction of a dramatically altered state of consciousness. Patients with anxiety, depr...
A blog at the intersection of philosophy, psychology, and mental health